How UK R&D Tax Credits Work After the 2024 Reforms

How UK R&D Tax Credits Work After the 2024 Reforms

The UK R&D tax credits underwent their most significant transformation in over two decades. Moreover, the merged scheme took effect for accounting periods beginning on or after 1 April 2024. The reform combined two existing schemes into a single merged framework. Additionally, the Research and Development Expenditure Credit (RDEC) aimed at large companies, while the SME R&D Relief targeted smaller businesses. However, HMRC described the change as a simplification, though in practice it represented a major shift of the tax benefit. Consequently, it's more generous for larger companies and RDEC-eligible SMEs but much less generous for unprofitable smaller businesses that had previously claimed under the enhanced SME scheme.

The UK's R&D tax relief system was introduced in 2000 under the Finance Act 2000. Initially, it was designed for small and medium-sized enterprises to address a market failure. Furthermore, private firms systematically underinvest in research and development because the returns spill over to competitors and the economy at large rather than going solely to the investing company. Therefore, by reducing the effective cost of R&D through tax relief, the government sought to bring UK business R&D spending closer to OECD average levels. Nevertheless, that goal has been only partly achieved, as UK business R&D intensity remains below the OECD average at roughly 1.6% of GDP according to the Office for National Statistics.

How the Merged R&D Tax Credit Scheme Works

Under the merged R&D tax credit scheme, companies receive an above-the-line credit of 20% of qualifying R&D spending. Importantly, the credit is taxable income, which means the net benefit after corporation tax at 25% is 15%. For profitable companies that can use the credit to reduce their tax liability, this represents a direct reduction in the cost of R&D. However, for companies that generate a credit exceeding their tax liability in a given period, the excess can be paid out as a cash credit, subject to a cap based on the company's PAYE and National Insurance liabilities.

The 20% rate represents a major improvement over the old RDEC rate of 13%. Previously, the old rate delivered a net benefit of roughly 10.5% after tax. This change was intended partly to bring the UK's RDEC scheme into line with comparable regimes in France, Germany, and Australia. Additionally, it reflects a deliberate policy choice to favour the RDEC mechanism, which is above-the-line and more visible to decision-makers, over the below-the-line SME enhanced deduction that was largely invisible in the accounts of smaller businesses.

The R&D Intensive SME Carve-Out

The merged scheme's standard rates were less generous than the old enhanced SME scheme for loss-making companies. Recognising this, the government retained a separate enhanced rate for R&D intensive SMEs. Specifically, a company qualifies as R&D intensive if its qualifying R&D spending represents at least 30% of total spending in the relevant period. Notably, the threshold was reduced from 40% to 30% in April 2024.

R&D intensive SMEs can claim an enhanced credit rate of 27%. This delivers a net benefit of roughly 18.6% after corporation tax. For loss-making companies in this category, the effective support is much more valuable than the standard merged scheme rate and comparable to the old enhanced SME scheme's most favourable outcomes. Sectors most likely to benefit from the intensive SME carve-out include early-stage pharmaceutical development, advanced materials research, and deep technology software businesses where R&D spending makes up the majority of costs.

The challenge for many qualifying SMEs is demonstrating the 30% threshold. HMRC's guidelines require that the R&D spending figure used in the threshold calculation is correctly identified under the qualifying spending rules. Moreover, total spending must exclude certain categories such as capital spending not otherwise deductible. Getting the threshold analysis wrong can mean the difference between the standard 15% net benefit and the enhanced 18.6% rate.

What Counts as Qualifying R&D Spending

The definition of qualifying R&D for tax purposes follows HMRC R&D guidelines, which were published under the Finance Act 2000 for the Departments of Trade and Industry and Treasury. These were updated to reflect the merged scheme in 2024. The key concept is 'scientific or technological uncertainty'. Furthermore, the work must seek to achieve an advance in science or technology and involve overcoming uncertainty that competent professionals could not resolve without undertaking the R&D activity.

Qualifying spending categories include staffing costs for employees directly engaged in R&D, software costs, consumable materials, and subcontracted R&D with specific rules on attribution. From April 2023, the cost of data sets and cloud computing directly used in R&D also qualify. The inclusion of cloud computing costs was a major update that reflects the shift of computational R&D to remote infrastructure.

HMRC's scrutiny of R&D tax credit claims has intensified greatly since 2022. The tax authority identified widespread abuse of the scheme by advisory firms who were filing inflated or entirely fabricated claims on behalf of clients. As a result, the number of compliance enquiries opened by HMRC's dedicated R&D unit increased by over 300% between 2021 and 2023, according to HMRC's own published statistics. Therefore, first-time claimants and companies claiming in novel sectors should anticipate a higher probability of enquiry and prepare their technical and financial documentation accordingly.

How to Claim R&D Tax Credits and What the Process Involves

Claims under the merged R&D scheme are made via the corporation tax return, supplemented by a technical narrative document and a spending breakdown. From August 2023, companies must notify HMRC of their intention to claim within six months from the end of the accounting period in which the R&D was undertaken. This notification requirement is new and catches many first-time claimants unaware. Importantly, missing the notification deadline eliminates the right to claim, regardless of the quality of the underlying R&D activity.

The technical narrative is the most important document in a compliant claim. It must identify the scientific or technological advance sought, explain the uncertainties involved, describe the systematic approach taken to resolve them, and demonstrate that the work went beyond what a competent professional could achieve without investigation. HMRC guidance warns explicitly that narratives that are generic, vague, or clearly generated without knowledge of the specific project will trigger enquiry.

The UK R&D tax credits system remains one of the more generous innovation incentives in the OECD, even after the 2024 reforms for profitable larger companies. However, for loss-making SMEs outside the intensive category, the reformed scheme is less valuable than its predecessor. Understanding which framework applies, calculating the threshold correctly, and assembling compliant documentation are the three practical tasks that determine whether a company realises the full benefit of the reformed system.

Fun fact: The UK's R&D tax relief system was introduced under the Finance Act 2000 and predates several of the industries it now mainly supports. When the original SME R&D tax credit was designed, broadband internet was still a premium luxury for most UK businesses, cloud computing did not yet exist as a commercial concept, and smartphone technology was over half a decade from its first consumer deployment.

The Bigger Policy Question

The 2024 reform reflects a genuine tension in UK innovation policy. Successive governments have wanted the R&D tax credit scheme to be both broad and tight. Broad means supporting the widest possible range of innovative activity, while tight means preventing abuse and directing subsidy toward genuinely productive R&D. The compliance tightening of 2022 to 2024 was combined with the structural reform of the merged scheme. This suggests the current government has resolved that tension in favour of more targeted support for large companies and genuinely R&D-intensive SMEs, at the cost of the accessibility that made the old enhanced SME scheme popular with smaller businesses.

Whether that trade-off improves UK business R&D intensity relative to GDP remains to be seen, as this is the underlying policy goal. It will be visible in ONS business spending on R&D data over the next three to five years. The most recent available data for 2023 showed no major acceleration in UK business R&D spending, despite the generous RDEC rate announced in 2022. Overall, structural investment barriers appear to be the binding constraint, not the tax rate alone.